Only a few studies exist on the Paul glaucoma device in children with glaucoma. Compared to Ahmed glaucoma Valve or Baerveldt implant, there is little evidence on the new glaucoma drainage implant in children.
Some small studies (1, 2) describe good IOP reduction in congenital and aphakic glaucoma children but numbers in these studies are low.
However, altough literature is rare on Paul Glaucoma implant in children yet, there is some evidence that this method can be recommended for some childhood glaucoma cases.
This has been proven by a recent randomized clinical trial including young children and adolescents ≤ 18 years with childhood glaucoma (3) comparing Paul glaucoma implant (PGI) to an Ahmed Glaucoma Valve (AGV). Paul Glaucoma implant showed slightly higher success rates compared to Ahmed Valve implant.
While current evidence on the efficacy of the Paul implant in children remains limited, early clinical experience is promising. As more pediatric -focused studies are underway, the Paul glaucoma implant may emerge as a valuable option, especially in cases where traditional glaucoma drainage devices present challenges.
References
Contributor: Esther Hoffmann, Eye Clinic, Unversity of Mainz
Tip of the Month Manager: Karin Øyo-Szerenyi
Tip of the Month Editors: Karl Mercieca, Francisco Goñi
Tip of the Month Editors in Chief: Manuele Michelessi, Francesco Oddone